Revisiting the concept of incretin and enteroendocrine L-cells as type 2 diabetes mellitus treatment. (2022)
Attributed to:
Aetiology and Mechanisms of Diabetes and Related Metabolic Disorders of Later Life
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.84224
Publication URI: https://www.repository.cam.ac.uk/handle/1810/336805
Type: Journal Article/Review